×
戻る Agenda
How will PREFER Patient Preference Studies Inform Decision-Makers about Patients’ Needs and Preferences
Session Chair(s)
Mireille Muller, DRSC, PHD, MSC
Regulatory Policy & Intelligence Director
Novartis Pharma AG, Switzerland
The PREFER researchers are currently testing different methods for preference elicitation in clinical case studies across different diseases: cancer, rheumatoid arthritis and neuromuscular disorders and will report about their progress.
Speaker(s)
Panelist
Telba Irony, PHD, MS, MSC
Janssen R&D, United States
Senior Scientific Director, Quantitative Sciences
Panelist
Irina Cleemput, PHD
Belgian Health Care Knowledge Centre (KCE), Belgium
Scientific Programme Director
Panelist
Florian S. Gutzwiller, DrMed, MPH
Novartis Pharma AG, Switzerland
Global HEOR Director